IPEC publishes GDP Audit Guideline for Pharmaceutical Excipients
Recommendation
6/7 October 2026
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The IPEC Good Distribution Practice (GDP) Audit Guideline for Pharmaceutical Excipients has been revised and the new version has been published. The previous version was published in 2008. The original version goes back to 2000.
The new document is designed in a questionnaire format to assist in evaluating the practices and quality systems of distributors who sell, store or repackage pharmaceutical excipients or any combination thereof. The audit guideline should be considered as the audit tool used in the evaluation of excipient distributors' GDP compliance, in accordance with the current IPEC GDP Guideline for Pharmaceutical Excipients (2006), which describes these principles in detail
Source: IPEC Press Release
Here you will find the IPEC Good Distribution Practice (GDP) Audit Guideline for Pharmaceutical Excipients
You can download the word version of the Guide here
Related GMP News
10.09.2026European GDP Association Developments May through August 2026
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September
10.09.2026GDP in the US: FDA Launches DSCSA Assessment for Small Dispensers and Issues Exemptions
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations